Loading...

Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial

OBJECTIVE: We investigated the efficacy and toxicity of tailored-dose chemotherapy with gemcitabine and irinotecan for platinum-refractory/resistant ovarian or primary peritoneal cancer. METHODS: We enrolled patients with ovarian or primary peritoneal cancer who received ≥2 previous chemotherapeutic...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Gynecol Oncol
Main Authors: Tate, Shinichi, Nishikimi, Kyoko, Matsuoka, Ayumu, Otsuka, Satoyo, Kato, Kazuyoshi, Takahashi, Yutaka, Shozu, Makio
Format: Artigo
Sprog:Inglês
Udgivet: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7767653/
https://ncbi.nlm.nih.gov/pubmed/33185049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!